Silex Systems commercialises laser isotope-separation technology through its 51%-owned GLE uranium-enrichment venture and wholly owned quantum-silicon and medical-isotope programs.
- Country
- United States
- Commodity
- U
- Stage
- Developer
Price-|MCap$888.3MUpdated Sep 2026